1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > India In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

India In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Summary

GlobalData’s new report, "India In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the India In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for In Vitro Diagnostics market.
- Global corporate-level profiles of key companies operating within the India In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

India In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 13
2.1 What Is This Report About? 13
2.2 In Vitro Diagnostics Market Segmentation 13
2.3 Definitions of Markets Covered in the Report 16
3 In Vitro Diagnostics Market, India 29
3.1 In Vitro Diagnostics Market, India, Revenue ($m), 2007-2021 29
3.2 In Vitro Diagnostics Market, India, Revenue Mix ($m), 2014 31
3.3 In Vitro Diagnostics Market, India, Category Contribution by Revenue ($m), 2014 32
3.4 In Vitro Diagnostics Market, Japan, Category Comparison by Revenue ($m), 2007-2021 33
3.5 In Vitro Diagnostics Market, India, Revenue ($m), 2007-2014 35
3.6 In Vitro Diagnostics Market, India, Revenue ($m), 2014-2021 37
3.7 In Vitro Diagnostics Market, India, Company Share by Revenue ($m), 2014 39
4 Clinical Chemistry Market, India 41
4.1 Clinical Chemistry Market, India, Revenue Mix ($m), 2014 41
4.2 Clinical Chemistry Market, India, Segment Contribution (%), 2014 42
4.3 Clinical Chemistry Market, India, Revenue ($m), 2007-2014 44
4.4 Clinical Chemistry Market, India, Revenue ($m), 2014-2021 46
4.4.1 Clinical Chemistry Analyzers Market, India, Revenue ($m), by Segment, 2007-2014 48
4.4.2 Therapeutic Drug Monitoring Market, India, Revenue ($m), by Segment, 2007-2014 50
4.4.3 Urine Analysis Market, India, Revenue ($m), by Segment, 2007-2014 52
4.4.4 Clinical Chemistry Analyzers Market, India, Revenue ($m), by Segment, 2014-2021 54
4.4.5 Therapeutic Drug Monitoring Market, India, Revenue ($m), by Segment, 2014-2021 56
4.4.6 Urine Analysis Market, India, Revenue ($m), by Segment, 2014-2021 58
4.5 Clinical Chemistry Market, India, Distribution Share by Revenue ($m), 2013-2014 60
4.6 Clinical Chemistry Market, India, Company Share by Revenue ($m), 2014 61
5 Genetic Testing Market, India 63
5.1 Genetic Testing Market, India, Revenue Mix ($m), 2014 63
5.2 Genetic Testing Market, India, Segment Contribution (%), 2014 64
5.3 Genetic Testing Market, India, Revenue ($m), 2007-2014 65
5.4 Genetic Testing Market, India, Revenue ($m), 2014-2021 67
5.5 Genetic Testing Market, India, Distribution Share by Revenue ($m), 2013-2014 69
5.6 Genetic Testing Market, India, Company Share by Revenue ($m), 2014 70
6 Haematology Market, India 72
6.1 Haematology Market, India, Revenue Mix ($m), 2014 72
6.2 Haematology Market, India, Segment Contribution (%), 2014 73
6.3 Haematology Market, India, Revenue ($m), 2007-2014 74
6.4 Haematology Market, India, Revenue ($m), 2014-2021 76
6.4.1 Haematology Cell Counters Market, India, Revenue ($m), by Segment, 2007-2014 78
6.4.2 Haematology Rapid Tests and POC Market, India, Revenue ($m), by Segment, 2007-2014 80
6.4.3 Haematology Reagents Market, India, Revenue ($m), by Segment, 2007-2014 82
6.4.4 Haemostasis Market, India, Revenue ($m), by Segment, 2007-2014 84
6.4.5 Immunohaematology Market, India, Revenue ($m), by Segment, 2007-2014 86
6.4.6 Haematology Cell Counters Market, India, Revenue ($m), by Segment, 2014-2021 88
6.4.7 Haematology Rapid Tests and POC Market, India, Revenue ($m), by Segment, 2014-2021 90
6.4.8 Haematology Reagents Market, India, Revenue ($m), by Segment, 2014-2021 92
6.4.9 Haemostasis Market, India, Revenue ($m), by Segment, 2014-2021 94
6.4.10 Immunohaematology Market, India, Revenue ($m), by Segment, 2014-2021 96
6.5 Haematology Market, India, Distribution Share by Revenue ($m), 2013-2014 98
6.6 Haematology Market, India, Company Share by Revenue ($m), 2014 99
7 Histology And Cytology Market, India 101
7.1 Histology And Cytology Market, India, Revenue Mix ($m), 2014 101
7.2 Histology And Cytology Market, India, Segment Contribution (%), 2014 102
7.3 Histology And Cytology Market, India, Revenue ($m), 2007-2014 103
7.4 Histology And Cytology Market, India, Revenue ($m), 2014-2021 105
7.5 Histology And Cytology Market, India, Distribution Share by Revenue ($m), 2013-2014 107
7.6 Histology And Cytology Market, India, Company Share by Revenue ($m), 2014 108
8 Immuno Chemistry Market, India 110
8.1 Immuno Chemistry Market, India, Revenue Mix ($m), 2014 110
8.2 Immuno Chemistry Market, India, Segment Contribution (%), 2014 111
8.3 Immuno Chemistry Market, India, Revenue ($m), 2007-2014 113
8.4 Immuno Chemistry Market, India, Revenue ($m), 2014-2021 115
8.4.1 Anemia Tests Market, India, Revenue ($m), by Segment, 2007-2014 117
8.4.2 Disease Specific Immunochemistry Market, India, Revenue ($m), by Segment, 2007-2014 119
8.4.3 Endocrinology Tests Market, India, Revenue ($m), by Segment, 2007-2014 121
8.4.4 IgE Allergy Blood Tests Market, India, Revenue ($m), by Segment, 2007-2014 123
8.4.5 Immunochemistry Analyzers Market, India, Revenue ($m), by Segment, 2007-2014 125
8.4.6 Immunochemistry Rapid Tests and POC Market, India, Revenue ($m), by Segment, 2007-2014 127
8.4.7 Vitamins Tests Market, India, Revenue ($m), by Segment, 2007-2014 129
8.4.8 Anemia Tests Market, India, Revenue ($m), by Segment, 2014-2021 131
8.4.9 Disease Specific Immunochemistry Market, India, Revenue ($m), by Segment, 2014-2021 133
8.4.10 Endocrinology Tests Market, India, Revenue ($m), by Segment, 2014-2021 135
8.4.11 IgE Allergy Blood Tests Market, India, Revenue ($m), by Segment, 2014-2021 137
8.4.12 Immunochemistry Analyzers Market, India, Revenue ($m), by Segment, 2014-2021 139
8.4.13 Immunochemistry Rapid Tests and POC Market, India, Revenue ($m), by Segment, 2014-2021 141
8.4.14 Vitamins Tests Market, India, Revenue ($m), by Segment, 2014-2021 143
8.5 Immuno Chemistry Market, India, Distribution Share by Revenue ($m), 2013-2014 145
8.6 Immuno Chemistry Market, India, Company Share by Revenue ($m), 2014 146
9 Infectious Diagnostics Market, India 148
9.1 Infectious Diagnostics Market, India, Revenue Mix ($m), 2014 148
9.2 Infectious Diagnostics Market, India, Segment Contribution (%), 2014 149
9.3 Infectious Diagnostics Market, India, Revenue ($m), 2007-2014 151
9.4 Infectious Diagnostics Market, India, Revenue ($m), 2014-2021 153
3.2.1 Infectious Diagnostics Rapid Tests and POC Market, India, Revenue ($m), by Segment, 2007-2014 155
3.2.2 Infectious Diagnostics Rapid Tests and POC Market, India, Revenue ($m), by Segment, 2014-2021 157
9.5 Infectious Diagnostics Market, India, Distribution Share by Revenue ($m), 2013-2014 159
9.6 Infectious Diagnostics Market, India, Company Share by Revenue ($m), 2014 160
10 Microbiology Culture Market, India 162
10.1 Microbiology Culture Market, India, Revenue Mix ($m), 2014 162
10.2 Microbiology Culture Market, India, Segment Contribution (%), 2014 163
10.3 Microbiology Culture Market, India, Revenue ($m), 2007-2014 165
10.4 Microbiology Culture Market, India, Revenue ($m), 2014-2021 167
10.4.1 Microbiology Analyzers Market, India, Revenue ($m), by Segment, 2007-2014 169
10.4.2 Microbiology Analyzers Market, India, Revenue ($m), by Segment, 2014-2021 171
10.5 Microbiology Culture Market, India, Distribution Share by Revenue ($m), 2013-2014 173
10.6 Microbiology Culture Market, India, Company Share by Revenue ($m), 2014 174
11 Overview of Key Companies in India, In Vitro Diagnostics Market 176
11.1 Siemens Healthcare 176
11.1.1 Company Overview 176
11.2 F. Hoffmann-La Roche Ltd. 176
11.2.1 Company Overview 176
11.3 Transasia Bio-Medicals Ltd. 176
11.3.1 Company Overview 176
11.4 Danaher Corporation 177
11.4.1 Company Overview 177
11.5 Abbott Laboratories 177
11.5.1 Company Overview 177
11.6 Becton, Dickinson and Company 177
11.6.1 Company Overview 177
11.7 Sysmex Corporation 177
11.7.1 Company Overview 177
11.8 Himedia Laboratories Pvt. Ltd. 178
11.8.1 Company Overview 178
11.9 Trivitron Healthcare Pvt Ltd. 178
11.9.1 Company Overview 178
11.10 bioMerieux S.A. 178
11.10.1 Company Overview 178
11.11 Alere Inc. 179
11.11.1 Company Overview 179
11.12 PerkinElmer, Inc. 179
11.12.1 Company Overview 179
11.13 Bio-Rad Laboratories, Inc. 179
11.13.1 Company Overview 179
11.14 Span Diagnostics Ltd. 180
11.14.1 Company Overview 180
11.15 Agappe Diagnostics Ltd. 180
11.15.1 Company Overview 180
11.16 Ortho-Clinical Diagnostics Inc. 180
11.16.1 Company Overview 180
12 In Vitro Diagnostics Market Pipeline Products 181
13 Financial Deals Landscape 187
13.1 Acquisition 187
13.1.1 Tosoh Acquires Lilac Medicare, In-Vitro Diagnostics Company 187
13.1.2 Span Diagnostics to Divest 45% Stake in Span Nihon Kohden Diagnostics to Nihon Kohden 188
13.2 Equity Offerings 189
13.2.1 Transasia Bio-Medicals Plans to Raise Funds through IPO 189
13.3 Partnerships 190
13.3.1 Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 190
13.3.2 Seegene Enters into Co-Development Agreement with BD Life Sciences 191
13.3.3 OriGene Technologies Enters into Licensing Agreement with Diadexus 192
13.3.4 MdxHealth Enters into Licensing Agreement with Erasmus MC 193
13.3.5 Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 194
13.3.6 Sigma-Aldrich Enters into Distribution Agreement with LGC 195
13.3.7 OvaGene Oncology Enters into Agreement with Etta Healthcare 196
13.3.8 InTouch Health Enters into Agreement with iSchemaView 197
13.3.9 IBA Partners with Philips India 198
13.3.10 Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 199
13.3.11 Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 200
13.3.12 DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 201
13.3.13 IncellDx Enters into Licensing Agreement with Claremont BioSolutions 202
13.3.14 Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 203
13.3.15 AngioDynamics Enters into Licensing Agreement with EmboMedics 204
13.3.16 Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 205
13.3.17 Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 206
13.3.18 Biocartis Enters into Licensing and Development Agreement with Microbiome 207
13.3.19 CBScientific Enters into Distribution Agreement with UTest 208
13.3.20 GeneThera Enters into Co-Development Agreement with Hudson Robotics 209
13.3.21 Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 210
13.3.22 Sapien Biosciences Enters into Development Agreement with OncoStem Diagnostics 211
13.3.23 Genomic Vision Extends Agreement with Quest Diagnostics 212
13.3.24 Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 213
13.3.25 Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 215
13.3.26 BioMerieux Enters into Licensing Agreement with Astute Medical 216
13.3.27 MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 217
13.3.28 NoemaLife Enters into Distribution Agreement with Horiba Medical 218
13.3.29 Foundation for Innovative New Diagnostics Enters into Agreement with Molbio Diagnostics 219
13.3.30 Clinical Genomics Enters into Licensing Agreement with CSIRO 220
13.4 Private Equity 221
13.4.1 Manipal Education and Medical Group International May Acquire Medall Healthcare 221
13.5 Venture Financing 223
13.5.1 Wrig Nanosystems Raises USD2.3 Million 223
13.5.2 Mapmygenome Raises USD1.1 Million in Pre-Series A Venture Financing 224
14 Recent Developments 225
14.1 Corporate Communications 225
14.1.1 Jun 08, 2015: Celator Pharmaceuticals Announces Expansion of Clinical Study in Patients with Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia at High-Risk of Treatment-Related Mortality 225
14.1.2 Nov 12, 2014: Popular Science Recognizes Convergent Dental's Solea CO2 Laser with Best of What's New Award 225
14.2 Financial Announcements 226
14.2.1 Dec 13, 2014: Sri Ramakrishna Hospital Inaugurates Discovery IQ PET/CT System In Tamil Nadu, India 226
14.2.2 Nov 13, 2014: Morepen Laboratories Reports Revenue Of INR1.7 Billion In H1 Fiscal 2014 227
14.3 Other Significant Developments 228
14.3.1 Aug 18, 2015: Ortho Clinical Diagnostics Selects Model N for Global Deployment of Revvy Configure Price Quote for Medical Technologies 228
14.3.2 Nov 05, 2014: Bearing Analytics Changes Name To DATTUS, Opens Office In India 228
14.4 Product News 229
14.4.1 Apr 21, 2015: Cancer Genetics Expands Next-Generation Sequencing Capabilities in India Through Launch of Solid Tumor Hotspot Panel for Biopharma and Clinical Customers Throughout Asia 229
14.4.2 Mar 03, 2015: Molbio Diagnostics Develops Swine Flu Diagnostic Kit 230
14.5 Strategy And Business Planning 230
14.5.1 Aug 26, 2015: Pressure BioSciences and the Institute of Bioinformatics Announce Comprehensive Two Year Collaboration 230
14.5.2 Dec 21, 2014: Siemens Healthcare Likely To Expand Manufacturing Base In India 231
14.5.3 Nov 06, 2014: Takeda Announces Abstracts for Ixazomib in Multiple Myeloma to be Presented at 56th American Society of Hematology Annual Meeting 232
14.5.4 Nov 06, 2014: Analytik Jena Establishes Subsidiary in India 233
15 Appendix 235
15.1 Research Methodology 236
15.1.1 Coverage 236
15.1.2 Secondary Research 236
15.1.3 Primary Research 236
15.1.4 Company Share Analysis 237
15.1.5 Distribution Share Analysis 237
15.2 GlobalData Consulting 237
15.3 Contact Us 237
15.4 Disclaimer 238

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, India, Revenue ($m), USD Constant, 2007-2021 30
Table 2: In Vitro Diagnostics Market, India, Category Contribution by Revenue ($m), 2014 32
Table 3: In Vitro Diagnostics Market, Japan, Category Comparison by Revenue ($m), USD Constant, 2007-2021 34
Table 4: In Vitro Diagnostics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 36
Table 5: In Vitro Diagnostics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Table 6: In Vitro Diagnostics Market, India, Company Share by Revenue ($m), USD Constant, 2014 40
Table 7: Clinical Chemistry Market, India, Segment Contribution (%), 2014 43
Table 8: Clinical Chemistry Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 45
Table 9: Clinical Chemistry Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 47
Table 10: Clinical Chemistry Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 49
Table 11: Therapeutic Drug Monitoring Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 51
Table 12: Urine Analysis Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 53
Table 13: Clinical Chemistry Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Table 14: Therapeutic Drug Monitoring Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 57
Table 15: Urine Analysis Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 59
Table 16: Clinical Chemistry Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014 60
Table 17: Clinical Chemistry Market, India, Company Share by Revenue ($m), USD Constant, 2014 62
Table 18: Genetic Testing Market, India, Segment Contribution (%), 2014 64
Table 19: Genetic Testing Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 66
Table 20: Genetic Testing Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 68
Table 21: Genetic Testing Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014 69
Table 22: Genetic Testing Market, India, Company Share by Revenue ($m), USD Constant, 2014 71
Table 23: Haematology Market, India, Segment Contribution (%), 2014 73
Table 24: Haematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 75
Table 25: Haematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 77
Table 26: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 79
Table 27: Haematology Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 81
Table 28: Haematology Reagents Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 83
Table 29: Haemostasis Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 85
Table 30: Immunohaematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 87
Table 31: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 89
Table 32: Haematology Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 91
Table 33: Haematology Reagents Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 93
Table 34: Haemostasis Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Table 35: Immunohaematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 97
Table 36: Haematology Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014 98
Table 37: Haematology Market, India, Company Share by Revenue ($m), USD Constant, 2014 100
Table 38: Histology And Cytology Market, India, Segment Contribution (%), 2014 102
Table 39: Histology And Cytology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 104
Table 40: Histology And Cytology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 106
Table 41: Histology And Cytology Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014 107
Table 42: Histology And Cytology Market, India, Company Share by Revenue ($m), USD Constant, 2014 109
Table 43: Immuno Chemistry Market, India, Segment Contribution (%), 2014 112
Table 44: Immuno Chemistry Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 114
Table 45: Immuno Chemistry Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 116
Table 46: Anemia Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 118
Table 47: Disease Specific Immunochemistry Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 120
Table 48: Endocrinology Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 122
Table 49: IgE Allergy Blood Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 124
Table 50: Immunochemistry Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 126
Table 51: Immunochemistry Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 128
Table 52: Vitamins Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 130
Table 53: Anemia Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 132
Table 54: Disease Specific Immunochemistry Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 134
Table 55: Endocrinology Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 136
Table 56: IgE Allergy Blood Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 138
Table 57: Immunochemistry Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 140
Table 58: Immunochemistry Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 142
Table 59: Vitamins Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 144
Table 60: Immuno Chemistry Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014 145
Table 61: Immuno Chemistry Market, India, Company Share by Revenue ($m), USD Constant, 2014 147
Table 62: Infectious Diagnostics Market, India, Segment Contribution (%), 2014 150
Table 63: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 152
Table 64: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 154
Table 65: Infectious Diagnostics Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 156
Table 66: Infectious Diagnostics Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 158
Table 67: Infectious Diagnostics Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014 159
Table 68: Infectious Diagnostics Market, India, Company Share by Revenue ($m), USD Constant, 2014 161
Table 69: Microbiology Culture Market, India, Segment Contribution (%), 2014 164
Table 70: Microbiology Culture Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 166
Table 71: Microbiology Culture Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 168
Table 72: Microbiology Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 170
Table 73: Microbiology Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 172
Table 74: Microbiology Culture Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014 173
Table 75: Microbiology Culture Market, India, Company Share by Revenue ($m), USD Constant, 2014 175
Table 76: In Vitro Diagnostics Market Pipeline Products 181
Table 77: Tosoh Acquires Lilac Medicare, In-Vitro Diagnostics Company 187
Table 78: Span Diagnostics to Divest 45% Stake in Span Nihon Kohden Diagnostics to Nihon Kohden 188
Table 79: Transasia Bio-Medicals Plans to Raise Funds through IPO 189
Table 80: Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 190
Table 81: Seegene Enters into Co-Development Agreement with BD Life Sciences 191
Table 82: OriGene Technologies Enters into Licensing Agreement with Diadexus 192
Table 83: MdxHealth Enters into Licensing Agreement with Erasmus MC 193
Table 84: Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 194
Table 85: Sigma-Aldrich Enters into Distribution Agreement with LGC 195
Table 86: OvaGene Oncology Enters into Agreement with Etta Healthcare 196
Table 87: InTouch Health Enters into Agreement with iSchemaView 197
Table 88: IBA Partners with Philips India 198
Table 89: Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 199
Table 90: Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 200
Table 91: DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 201
Table 92: IncellDx Enters into Licensing Agreement with Claremont BioSolutions 202
Table 93: Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 203
Table 94: AngioDynamics Enters into Licensing Agreement with EmboMedics 204
Table 95: Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 205
Table 96: Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 206
Table 97: Biocartis Enters into Licensing and Development Agreement with Microbiome 207
Table 98: CBScientific Enters into Distribution Agreement with UTest 208
Table 99: GeneThera Enters into Co-Development Agreement with Hudson Robotics 209
Table 100: Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 210
Table 101: Sapien Biosciences Enters into Development Agreement with OncoStem Diagnostics 211
Table 102: Genomic Vision Extends Agreement with Quest Diagnostics 212
Table 103: Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 213
Table 104: Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 215
Table 105: BioMerieux Enters into Licensing Agreement with Astute Medical 216
Table 106: MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 217
Table 107: NoemaLife Enters into Distribution Agreement with Horiba Medical 218
Table 108: Foundation for Innovative New Diagnostics Enters into Agreement with Molbio Diagnostics 219
Table 109: Clinical Genomics Enters into Licensing Agreement with CSIRO 220
Table 110: Manipal Education and Medical Group International May Acquire Medall Healthcare 221
Table 111: Wrig Nanosystems Raises USD2.3 Million 223
Table 112: Mapmygenome Raises USD1.1 Million in Pre-Series A Venture Financing 224

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, India, Revenue ($m), USD Constant, 2007-2021 29
Figure 2: In Vitro Diagnostics Market, India, Revenue Mix ($m), 2014 31
Figure 3: In Vitro Diagnostics Market, India, Category Contribution (%), 2014 32
Figure 4: In Vitro Diagnostics Market, Japan, Category Comparison by Revenue ($m), USD Constant, 2007-2021 33
Figure 5: In Vitro Diagnostics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 35
Figure 6: In Vitro Diagnostics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 37
Figure 7: In Vitro Diagnostics Market, India, Company Share (%) 2014 39
Figure 8: Clinical Chemistry Market, India, Revenue Mix ($m), 2014 41
Figure 9: Clinical Chemistry Market, India, Segment Contribution (%), 2014 42
Figure 10: Clinical Chemistry Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 44
Figure 11: Clinical Chemistry Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 46
Figure 12: Clinical Chemistry Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 48
Figure 13: Therapeutic Drug Monitoring Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 50
Figure 14: Urine Analysis Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 52
Figure 15: Clinical Chemistry Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 54
Figure 16: Therapeutic Drug Monitoring Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Figure 17: Urine Analysis Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 58
Figure 18: Clinical Chemistry Market, India, Company Share (%) 2014 61
Figure 19: Genetic Testing Market, India, Revenue Mix ($m), 2014 63
Figure 20: Genetic Testing Market, India, Segment Contribution (%), 2014 64
Figure 21: Genetic Testing Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 65
Figure 22: Genetic Testing Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 67
Figure 23: Genetic Testing Market, India, Company Share (%) 2014 70
Figure 24: Haematology Market, India, Revenue Mix ($m), 2014 72
Figure 25: Haematology Market, India, Segment Contribution (%), 2014 73
Figure 26: Haematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 74
Figure 27: Haematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 76
Figure 28: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 78
Figure 29: Haematology Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 80
Figure 30: Haematology Reagents Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 82
Figure 31: Haemostasis Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 84
Figure 32: Immunohaematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 86
Figure 33: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 88
Figure 34: Haematology Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 90
Figure 35: Haematology Reagents Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 92
Figure 36: Haemostasis Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 94
Figure 37: Immunohaematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 96
Figure 38: Haematology Market, India, Company Share (%) 2014 99
Figure 39: Histology And Cytology Market, India, Revenue Mix ($m), 2014 101
Figure 40: Histology And Cytology Market, India, Segment Contribution (%), 2014 102
Figure 41: Histology And Cytology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 103
Figure 42: Histology And Cytology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 105
Figure 43: Histology And Cytology Market, India, Company Share (%) 2014 108
Figure 44: Immuno Chemistry Market, India, Revenue Mix ($m), 2014 110
Figure 45: Immuno Chemistry Market, India, Segment Contribution (%), 2014 111
Figure 46: Immuno Chemistry Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 113
Figure 47: Immuno Chemistry Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 115
Figure 48: Anemia Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 117
Figure 49: Disease Specific Immunochemistry Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 119
Figure 50: Endocrinology Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 121
Figure 51: IgE Allergy Blood Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 123
Figure 52: Immunochemistry Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 125
Figure 53: Immunochemistry Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 127
Figure 54: Vitamins Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 129
Figure 55: Anemia Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 131
Figure 56: Disease Specific Immunochemistry Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 133
Figure 57: Endocrinology Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 135
Figure 58: IgE Allergy Blood Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 137
Figure 59: Immunochemistry Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 139
Figure 60: Immunochemistry Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 141
Figure 61: Vitamins Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 143
Figure 62: Immuno Chemistry Market, India, Company Share (%) 2014 146
Figure 63: Infectious Diagnostics Market, India, Revenue Mix ($m), 2014 148
Figure 64: Infectious Diagnostics Market, India, Segment Contribution (%), 2014 149
Figure 65: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 151
Figure 66: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 153
Figure 67: Infectious Diagnostics Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 155
Figure 68: Infectious Diagnostics Rapid Tests and POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 157
Figure 69: Infectious Diagnostics Market, India, Company Share (%) 2014 160
Figure 70: Microbiology Culture Market, India, Revenue Mix ($m), 2014 162
Figure 71: Microbiology Culture Market, India, Segment Contribution (%), 2014 163
Figure 72: Microbiology Culture Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 165
Figure 73: Microbiology Culture Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 167
Figure 74: Microbiology Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 169
Figure 75: Microbiology Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 171
Figure 76: Microbiology Culture Market, India, Company Share (%) 2014 174

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.